EW Edwards Lifesciences Corp

Price (delayed)

$117.07

Market cap

$72.97B

P/E Ratio

50.03

Dividend/share

N/A

EPS

$2.34

Enterprise value

$72.34B

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of ...

Highlights
The company's EPS has surged by 97% YoY and by 73% QoQ
The net income has soared by 97% YoY and by 72% from the previous quarter
The price to earnings (P/E) is 14% lower than the last 4 quarters average of 59.5 but 7% higher than the 5-year quarterly average of 47.8

Key stats

What are the main financial stats of EW
Market
Shares outstanding
623.33M
Market cap
$72.97B
Enterprise value
$72.34B
Valuations
Price to earnings (P/E)
50.03
Price to book (P/B)
14.18
Price to sales (P/S)
14.79
EV/EBIT
43.32
EV/EBITDA
39.63
EV/Sales
14.69
Earnings
Revenue
$4.93B
EBIT
$1.67B
EBITDA
$1.83B
Free cash flow
$1.05B
Per share
EPS
$2.34
Free cash flow per share
$1.69
Book value per share
$8.26
Revenue per share
$7.91
TBVPS
$9.9
Balance sheet
Total assets
$7.66B
Total liabilities
$2.53B
Debt
$684.2M
Equity
$5.13B
Working capital
$2.44B
Liquidity
Debt to equity
0.13
Current ratio
3.75
Quick ratio
2.55
Net debt/EBITDA
-0.34
Margins
EBITDA margin
37.1%
Gross margin
75.5%
Net margin
29.7%
Operating margin
30.9%
Efficiency
Return on assets
20.2%
Return on equity
31.5%
Return on invested capital
38.1%
Return on capital employed
24.6%
Return on sales
33.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EW stock price

How has the Edwards Lifesciences stock price performed over time
Intraday
-2.5%
1 week
-0.78%
1 month
0.58%
1 year
51.16%
YTD
28.32%
QTD
13.03%

Financial performance

How have Edwards Lifesciences's revenue and profit performed over time
Revenue
$4.93B
Gross profit
$3.72B
Operating income
$1.52B
Net income
$1.46B
Gross margin
75.5%
Net margin
29.7%
The net income has soared by 97% YoY and by 72% from the previous quarter
The operating income has soared by 93% YoY and by 63% from the previous quarter
The net margin has soared by 73% YoY and by 56% from the previous quarter
The company's operating margin has surged by 69% YoY and by 48% QoQ

Growth

What is Edwards Lifesciences's growth rate over time

Valuation

What is Edwards Lifesciences stock price valuation
P/E
50.03
P/B
14.18
P/S
14.79
EV/EBIT
43.32
EV/EBITDA
39.63
EV/Sales
14.69
The company's EPS has surged by 97% YoY and by 73% QoQ
The price to earnings (P/E) is 14% lower than the last 4 quarters average of 59.5 but 7% higher than the 5-year quarterly average of 47.8
The stock's price to book (P/B) is 43% more than its 5-year quarterly average of 10.2 and 21% more than its last 4 quarters average of 12.0
The equity has grown by 34% year-on-year and by 10% since the previous quarter
The P/S is 60% above the 5-year quarterly average of 9.5 and 23% above the last 4 quarters average of 12.3
EW's revenue is up by 14% year-on-year and by 10% since the previous quarter

Efficiency

How efficient is Edwards Lifesciences business performance
The company's return on sales has surged by 76% YoY and by 58% QoQ
EW's return on assets has surged by 70% year-on-year and by 64% since the previous quarter
Edwards Lifesciences's return on equity has surged by 67% YoY and by 60% QoQ
The company's return on invested capital has surged by 66% QoQ and by 64% YoY

Dividends

What is EW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EW.

Financial health

How did Edwards Lifesciences financials performed over time
EW's quick ratio is up by 29% year-on-year and by 2% since the previous quarter
The company's current ratio rose by 22% YoY but it fell by 2.3% QoQ
The debt is 87% less than the equity
The equity has grown by 34% year-on-year and by 10% since the previous quarter
The company's debt to equity fell by 28% YoY and by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.